Don Staunton
President and Chief Scientific Officer
Pharmaceutical Sciences
CisThera
Canada
Biography
Dr. Staunton has been directing drug discovery and development activities for 16 years. Dr. Staunton was previously a Scientific Fellow at ICOS Corporation. His group discovered small molecule inhibitors of the integrin LFA-1 and PI3K which have entered clinical trials for autoimmune diseases and cancer. Dr. Staunton has published over 60 original science articles and reviews. He is an internationally recognized expert in cell adhesion biology, which plays a critical role in many disease processes. Don received his PhD in immunology at Tufts University School of Medicine. His post-doctoral training was under Dr Timothy Springer at Harvard Medical School where he subsequently became an Assistant Professor.
Research Interest
Pharmaceutical Sciences
